| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | alisertib | CTRPv2 | pan-cancer | AAC | -0.13 | 4e-05 |
| mRNA | prima-1 | CTRPv2 | pan-cancer | AAC | -0.13 | 5e-05 |
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.14 | 6e-05 |
| mRNA | decitabine | CTRPv2 | pan-cancer | AAC | -0.11 | 7e-05 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | -0.13 | 7e-05 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.15 | 7e-05 |
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.14 | 7e-05 |
| mRNA | PD-0325901 | gCSI | pan-cancer | AAC | 0.21 | 8e-05 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |